
    
      Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination
      according to the clinical guidelines. Two doses will be given, in 3-week interval.

      In these patients we will measure the specific antibody production. Blood sample 5 ml will be
      drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.
    
  